Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Gilead Sciences, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP), and the World Hepatitis Alliance (WHA) Collaborate to Support Elimination of Hepatitis by 2030 2021-11-23 11:00
EZZ accelerates genomic health focus with launch of two new biotic products 2021-11-23 04:00
Arctic Vision Announces First Patient Dosed in Phase III Study of ARVN001 for Treatment of Macular Edema Associated with Uveitis (UME) 2021-11-22 23:17
Getinge accelerates growth and productivity to reach new financial targets 2021-11-22 21:50
Ascentage Pharma's Olverembatinib Granted Orphan Designation by the European Commission for the Treatment of Chronic Myeloid Leukemia 2021-11-22 21:24
Alterity Therapeutics to Participate in Two Upcoming Investor Conferences 2021-11-22 20:50
Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines 2021-11-22 20:00
CARsgen Receives CTA Authorization from Health Canada for CLDN18.2-targeted CAR T-cell Product CT041 2021-11-22 20:00
Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech 2021-11-22 09:24
DSM recognized for advancing sustainable food commitments and novel science-based solutions across Asia Pacific 2021-11-22 09:00
Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index 2021-11-22 08:00
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:09
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:02
US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics 2021-11-20 08:00
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time 2021-11-19 18:52
Vazyme Attends Medica 2021 in Germany to Accelerate Its Global Market Expansion 2021-11-19 15:18
ASRA 2021 | Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, a Long-Acting Ropivacaine 2021-11-19 13:14
Treating Patients Beyond Borders - Antengene Successfully Hosted Its First R&D Day 2021-11-19 13:00
Antengene Announces IND Approval in China for a Phase I/II Study of Selinexor (ATG-010) in Patients with Non-Hodgkin Lymphoma 2021-11-19 08:30
Tavotek Biotherapeutics Announces Completion of Round B Financing with $35 Million 2021-11-19 08:00
1 208 209 210 211 212 452